Primary and metastatic rhabdomyosarcoma in the breast: Neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study

D. M. Hays, S. S. Donaldson, H. Shimada, W. M. Crist, Jr Newton, R. J. Andrassy, E. Wiener, J. Green, T. Triche, H. M. Maurer

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

The occurrence of rhabdomyosarcoma (RMS) primary in or metastatic to breast has been regarded as an uncommon event, associated with an unfavorable outcome. Records of 26 patients with diagnoses of breast RMS, either primary or secondary, entered in the Intergroup Rhabdomyosarcoma Study (IRS) (1972- 1992) were reviewed and compared with data regarding 47 similar patients in published reports. Of the 26 IRS cases, the histologic subtype was alveolar in 24, embryonal in 1, and not determined in 1. All were female with ages ranging from 11.5 to 20.2 years (median, 15.2 years; mode, 14-16 years). This compact age distribution of both primary (n = 7) and metastatic (n = 19) breast RMS was seen in previously reported series. Among the 19 cases of RMS with initial dissemination to breast, primary tumor sites were: extremity (n = 8), nasopharynx/paranasal sinuses (n = 7), and trunk (n = 4). IRS treatment was risk-based according to site and extent of disease. Four of 7 patients with primary RMS remain disease free 2.9 to 7 years post diagnosis. Among 19 patients with RMS initially metastatic to breast, including 7 in IRS clinical group IV at original diagnosis, three are disease free at 7.6, 15.7 and 17.0 years. Conclusions: primary or metastatic RMS in breast is almost confined to adolescent females having tumors with alveolar histology. Approximately one- half of the patients with primary breast disease and 15% of those with metastatic breast disease as an initial recurrence are long-term survivors.

Original languageEnglish (US)
Pages (from-to)181-189
Number of pages9
JournalMedical and Pediatric Oncology
Volume29
Issue number3
DOIs
StatePublished - Jul 23 1997

Fingerprint

Rhabdomyosarcoma
Breast Neoplasms
Breast
Breast Diseases
Nasopharynx
Paranasal Sinuses
Age Distribution
Survivors
Histology
Extremities
Recurrence

Keywords

  • Adolescence
  • Alveolar
  • Breast
  • Rhabdomyosarcoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research

Cite this

Primary and metastatic rhabdomyosarcoma in the breast : Neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study. / Hays, D. M.; Donaldson, S. S.; Shimada, H.; Crist, W. M.; Newton, Jr; Andrassy, R. J.; Wiener, E.; Green, J.; Triche, T.; Maurer, H. M.

In: Medical and Pediatric Oncology, Vol. 29, No. 3, 23.07.1997, p. 181-189.

Research output: Contribution to journalArticle

Hays, D. M. ; Donaldson, S. S. ; Shimada, H. ; Crist, W. M. ; Newton, Jr ; Andrassy, R. J. ; Wiener, E. ; Green, J. ; Triche, T. ; Maurer, H. M. / Primary and metastatic rhabdomyosarcoma in the breast : Neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study. In: Medical and Pediatric Oncology. 1997 ; Vol. 29, No. 3. pp. 181-189.
@article{2394016e51df4a69bd2097a78c111ebf,
title = "Primary and metastatic rhabdomyosarcoma in the breast: Neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study",
abstract = "The occurrence of rhabdomyosarcoma (RMS) primary in or metastatic to breast has been regarded as an uncommon event, associated with an unfavorable outcome. Records of 26 patients with diagnoses of breast RMS, either primary or secondary, entered in the Intergroup Rhabdomyosarcoma Study (IRS) (1972- 1992) were reviewed and compared with data regarding 47 similar patients in published reports. Of the 26 IRS cases, the histologic subtype was alveolar in 24, embryonal in 1, and not determined in 1. All were female with ages ranging from 11.5 to 20.2 years (median, 15.2 years; mode, 14-16 years). This compact age distribution of both primary (n = 7) and metastatic (n = 19) breast RMS was seen in previously reported series. Among the 19 cases of RMS with initial dissemination to breast, primary tumor sites were: extremity (n = 8), nasopharynx/paranasal sinuses (n = 7), and trunk (n = 4). IRS treatment was risk-based according to site and extent of disease. Four of 7 patients with primary RMS remain disease free 2.9 to 7 years post diagnosis. Among 19 patients with RMS initially metastatic to breast, including 7 in IRS clinical group IV at original diagnosis, three are disease free at 7.6, 15.7 and 17.0 years. Conclusions: primary or metastatic RMS in breast is almost confined to adolescent females having tumors with alveolar histology. Approximately one- half of the patients with primary breast disease and 15{\%} of those with metastatic breast disease as an initial recurrence are long-term survivors.",
keywords = "Adolescence, Alveolar, Breast, Rhabdomyosarcoma",
author = "Hays, {D. M.} and Donaldson, {S. S.} and H. Shimada and Crist, {W. M.} and Jr Newton and Andrassy, {R. J.} and E. Wiener and J. Green and T. Triche and Maurer, {H. M.}",
year = "1997",
month = "7",
day = "23",
doi = "10.1002/(SICI)1096-911X(199709)29:3<181::AID-MPO4>3.0.CO;2-9",
language = "English (US)",
volume = "29",
pages = "181--189",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Primary and metastatic rhabdomyosarcoma in the breast

T2 - Neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study

AU - Hays, D. M.

AU - Donaldson, S. S.

AU - Shimada, H.

AU - Crist, W. M.

AU - Newton, Jr

AU - Andrassy, R. J.

AU - Wiener, E.

AU - Green, J.

AU - Triche, T.

AU - Maurer, H. M.

PY - 1997/7/23

Y1 - 1997/7/23

N2 - The occurrence of rhabdomyosarcoma (RMS) primary in or metastatic to breast has been regarded as an uncommon event, associated with an unfavorable outcome. Records of 26 patients with diagnoses of breast RMS, either primary or secondary, entered in the Intergroup Rhabdomyosarcoma Study (IRS) (1972- 1992) were reviewed and compared with data regarding 47 similar patients in published reports. Of the 26 IRS cases, the histologic subtype was alveolar in 24, embryonal in 1, and not determined in 1. All were female with ages ranging from 11.5 to 20.2 years (median, 15.2 years; mode, 14-16 years). This compact age distribution of both primary (n = 7) and metastatic (n = 19) breast RMS was seen in previously reported series. Among the 19 cases of RMS with initial dissemination to breast, primary tumor sites were: extremity (n = 8), nasopharynx/paranasal sinuses (n = 7), and trunk (n = 4). IRS treatment was risk-based according to site and extent of disease. Four of 7 patients with primary RMS remain disease free 2.9 to 7 years post diagnosis. Among 19 patients with RMS initially metastatic to breast, including 7 in IRS clinical group IV at original diagnosis, three are disease free at 7.6, 15.7 and 17.0 years. Conclusions: primary or metastatic RMS in breast is almost confined to adolescent females having tumors with alveolar histology. Approximately one- half of the patients with primary breast disease and 15% of those with metastatic breast disease as an initial recurrence are long-term survivors.

AB - The occurrence of rhabdomyosarcoma (RMS) primary in or metastatic to breast has been regarded as an uncommon event, associated with an unfavorable outcome. Records of 26 patients with diagnoses of breast RMS, either primary or secondary, entered in the Intergroup Rhabdomyosarcoma Study (IRS) (1972- 1992) were reviewed and compared with data regarding 47 similar patients in published reports. Of the 26 IRS cases, the histologic subtype was alveolar in 24, embryonal in 1, and not determined in 1. All were female with ages ranging from 11.5 to 20.2 years (median, 15.2 years; mode, 14-16 years). This compact age distribution of both primary (n = 7) and metastatic (n = 19) breast RMS was seen in previously reported series. Among the 19 cases of RMS with initial dissemination to breast, primary tumor sites were: extremity (n = 8), nasopharynx/paranasal sinuses (n = 7), and trunk (n = 4). IRS treatment was risk-based according to site and extent of disease. Four of 7 patients with primary RMS remain disease free 2.9 to 7 years post diagnosis. Among 19 patients with RMS initially metastatic to breast, including 7 in IRS clinical group IV at original diagnosis, three are disease free at 7.6, 15.7 and 17.0 years. Conclusions: primary or metastatic RMS in breast is almost confined to adolescent females having tumors with alveolar histology. Approximately one- half of the patients with primary breast disease and 15% of those with metastatic breast disease as an initial recurrence are long-term survivors.

KW - Adolescence

KW - Alveolar

KW - Breast

KW - Rhabdomyosarcoma

UR - http://www.scopus.com/inward/record.url?scp=0030860747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030860747&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-911X(199709)29:3<181::AID-MPO4>3.0.CO;2-9

DO - 10.1002/(SICI)1096-911X(199709)29:3<181::AID-MPO4>3.0.CO;2-9

M3 - Article

C2 - 9212842

AN - SCOPUS:0030860747

VL - 29

SP - 181

EP - 189

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -